230 related articles for article (PubMed ID: 37406003)
1. Financial burden of heart failure in Malaysia: A perspective from the public healthcare system.
Ong SC; Low JZ
PLoS One; 2023; 18(7):e0288035. PubMed ID: 37406003
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study.
Ong SC; Low JZ; Yew WY; Yen CH; Abdul Kader MASK; Liew HB; Abdul Ghapar AK
Front Cardiovasc Med; 2022; 9():971592. PubMed ID: 36407426
[TBL] [Abstract][Full Text] [Related]
3. Modelling the national economic burden of non-surgical periodontal management in specialist clinics in Malaysia using a markov model.
Anuwar AHK; Ng CW; Safii SH; Saub R; Ab-Murat N
BMC Oral Health; 2024 Mar; 24(1):346. PubMed ID: 38500175
[TBL] [Abstract][Full Text] [Related]
4. Provider cost of treating oral potentially malignant disorders and oral cancer in Malaysian public hospitals.
Raman S; Shafie AA; Abraham MT; Shim CK; Maling TH; Rajendran S; Cheong SC
PLoS One; 2021; 16(5):e0251760. PubMed ID: 33984051
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and socio-economic burden of heart failure in an aging society of South Korea.
Lee H; Oh SH; Cho H; Cho HJ; Kang HY
BMC Cardiovasc Disord; 2016 Nov; 16(1):215. PubMed ID: 27832754
[TBL] [Abstract][Full Text] [Related]
6. Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs.
Çavuşoğlu Y; Altay H; Aras D; Çelik A; Ertaş FS; Kılıçaslan B; Nalbantgil S; Temizhan A; Ural D; Yıldırımtürk Ö; Yılmaz MB
Balkan Med J; 2022 Jul; 39(4):282-289. PubMed ID: 35872647
[TBL] [Abstract][Full Text] [Related]
7. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers.
Yu X; Hao Y; Zhu Z; Zhang W; Liu B; Ma M; Zhang X; Wei N; Wang J; Liu F
Clin Drug Investig; 2023 Apr; 43(4):241-250. PubMed ID: 36929485
[TBL] [Abstract][Full Text] [Related]
8. Out-of-Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States.
Wang SY; Valero-Elizondo J; Ali HJ; Pandey A; Cainzos-Achirica M; Krumholz HM; Nasir K; Khera R
J Am Heart Assoc; 2021 Jul; 10(14):e022164. PubMed ID: 33998273
[TBL] [Abstract][Full Text] [Related]
9. Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
Lam CSP; Wood R; Vaduganathan M; Bueno H; Chin A; Luporini Saraiva G; Sörstadius E; Tritton T; Thomas J; Qin L
Clin Cardiol; 2021 May; 44(5):646-655. PubMed ID: 33704817
[TBL] [Abstract][Full Text] [Related]
10. Estimating the economic burden of influenza on the older population in Malaysia.
Mad Tahir NS; Ismail A; Aljunid SM; Abdul Aziz AF; Azzeri A; Alkhodary AA
PLoS One; 2023; 18(11):e0294260. PubMed ID: 37971972
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems.
Yingchoncharoen T; Wu TC; Choi DJ; Ong TK; Liew HB; Cho MC
Korean Circ J; 2021 Aug; 51(8):681-693. PubMed ID: 34227265
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
[TBL] [Abstract][Full Text] [Related]
13. Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy.
Chung ES; Rickard J; Lu X; DerSarkissian M; Zichlin ML; Cheung HC; Swartz N; Greatsinger A; Duh MS
Adv Ther; 2021 Jan; 38(1):441-467. PubMed ID: 33141415
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of sickle cell disease in Brazil.
Silva-Pinto AC; Costa FF; Gualandro SFM; Fonseca PBB; Grindler CM; Souza Filho HCR; Bueno CT; Cançado RD
PLoS One; 2022; 17(6):e0269703. PubMed ID: 35709301
[TBL] [Abstract][Full Text] [Related]
15. Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective.
Shafie AA; Wong JHY; Ibrahim HM; Mohammed NS; Chhabra IK
Orphanet J Rare Dis; 2021 Apr; 16(1):157. PubMed ID: 33827621
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
Oh SH; Ku H; Park KS
BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
[TBL] [Abstract][Full Text] [Related]
17. Economic Burden of Mental Illnesses in Pakistan.
Malik MA; Khan MM
J Ment Health Policy Econ; 2016 Sep; 19(3):155-66. PubMed ID: 27572143
[TBL] [Abstract][Full Text] [Related]
18. Inpatient Care Costs of COVID-19 in South Africa's Public Healthcare System.
Edoka I; Fraser H; Jamieson L; Meyer-Rath G; Mdewa W
Int J Health Policy Manag; 2022 Aug; 11(8):1354-1361. PubMed ID: 33949817
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of low back pain in KwaZulu-Natal, South Africa: A prevalence-based cost-of-illness analysis from the healthcare provider's perspective.
Kahere M; Ngcamphalala C; Östensson E; Ginindza T
PLoS One; 2022; 17(10):e0263204. PubMed ID: 36227919
[TBL] [Abstract][Full Text] [Related]
20. The incremental economic burden of heart failure: A population-based investigation from South Korea.
Cho H; Oh SH; Lee H; Cho HJ; Kang HY
PLoS One; 2018; 13(12):e0208731. PubMed ID: 30576328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
